Ticker

No recent analyst price targets found for SRNE.

Latest News for SRNE

Sorrento Voyage Announces Expanded Luxury Boat Tours and Proposal Experiences Along the Amalfi Coast

Sorrento Voyage has announced the expansion of its private boat tours and romantic proposal experiences across the Amalfi Coast and Capri, offering travelers personalized sea-based journeys led by its founding team. Sorrento, Italy--(Newsfile Corp. - January 5, 2026) - Sorrento Voyage, a private charter company based in Piano di Sorrento, has expanded its range of bespoke luxury boat tours and romantic experiences…

Newsfile Corp • Jan 5, 2026
Sorrento Therapeutics (NASDAQ:SRNE) and Cortexyme (NASDAQ:CRTX) Head to Head Analysis

Institutional and Insider Ownership 63.2% of Cortexyme shares are owned by institutional investors. Comparatively, 0.0% of Sorrento Therapeutics shares are owned by institutional investors. 27.9% of Cortexyme shares are owned by insiders. Comparatively, 2.6% of Sorrento Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money

Defense World • Jan 5, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for SRNE.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top